Quadria Group names Rahul Agarwal as Partner at HealthQuad

Published On 2025-06-24 06:28 GMT   |   Update On 2025-06-24 06:28 GMT

New Delhi: Quadria Group, a healthcare-focused private equity platform, has announced the appointment of Rahul Agarwal as Partner at HealthQuad, a healthcare-focused growth venture capital platform.

Rahul joins HealthQuad following a long and successful tenure at Quadria Capital, where he most recently served as Managing Director. As part of Quadria since its inception, Rahul has spent over 13 years playing a pivotal role in investments, scaling portfolio companies, fundraising, and, most importantly, delivering successful exits.

In his new role, Rahul will help shape and drive the future fund strategy of HealthQuad and will step in to lead the investment team and committee, majority of who have been instrumental in driving the success of HealthQuad Fund I and Fund II.

With over 18 years of experience in healthcare investing and fund management, Rahul brings a rare combination of institutional investment discipline, operational insight, and deep healthcare expertise across healthcare delivery, pharma and digital health. He has executed investment and exit transactions of over US$1.5b across India, Southeast Asia and US during his stint at Quadria at prior to that at Religare Global Asset Management and Evolvence India Fund.

This appointment comes at a strategic moment for HealthQuad, which recently announced the launch of HealthQuad Fund III, targeting a raise of up to US$300 million (including a greenshoes of US$100 million). As a successor to Funds I and II, Fund III aims to build on HealthQuad’s proven track record of backing pioneering healthcare ventures that have significantly enhanced access, affordability, and quality of healthcare across India.

Quadria Group intends to announce few more senior appointments to strengthen the investment and the operating capability at HealthQuad.

Dr. Amit Varma, Co-founder of HealthQuad, said, “We are delighted to welcome Rahul to the HealthQuad leadership team. As someone who has been deeply involved in the evolution of healthcare investing in India, he brings the wisdom, stability, and strategic vision needed to take our platform to the next level. His deep understanding of both the Quadria and HealthQuad ecosystems will help us unlock valuable network effects for our portfolio companies, going forward.”

Sunil Thakur, Co-founder of HealthQuad, added, “Rahul has been an integral force in shaping Quadria’s growth journey, earning deep trust and respect across the organization. His move to HealthQuad represents not just a strategic transition, but a powerful affirmation of our long-term vision. With his deep familiarity with the HealthQuad team and portfolio companies, Rahul’s integration will ensure seamless continuity while elevating the platform’s institutional strength.”

Rahul Agarwal, Partner at HealthQuad, shared, “HealthQuad represents the future of healthcare investing—driven by innovation, supported by a strong ecosystem, and grounded in the values of impact and scalability. I’m excited to join this exceptional team at a pivotal point in its journey. With Fund III, we have a unique opportunity to institutionalize early-stage healthcare investing in India and build category-defining companies. I look forward to contributing with the same passion and purpose that have defined my journey at Quadria.”

Rahul’s appointment comes as HealthQuad expands its strategic focus across high-growth sectors such as healthtech, medtech, biopharma, and digitally enabled care delivery models, while leveraging Quadria’s global investor base and healthcare ecosystem.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News